ASAH1 and glioblastoma: The efficacy of tamoxifen in a range of cancers, including to some degree in GBM/GSC, is proposed to be mediated by acid ceramidase inhibition[95], indicating a novel pathway for tamoxifen in the management of GBM/GSC.